Sanjay Shukla - 24 May 2022 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
President and CEO, Director
Signature
Nancy E. Denyes, attorney-in-fact
Issuer symbol
LIFE
Transactions as of
24 May 2022
Transactions value $
$0
Form type
4
Filing time
26 May 2022, 16:30:16 UTC
Previous filing
07 Feb 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Employee Stock Option (right to buy) Award $0 +516,280 $0.000000 516,280 24 May 2022 Common Stock 516,280 $2.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 24, 2022, such that this option will be fully exercisable on May 24, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.